Amrutanjan Health Care share price today

Amrutanjan Health Care Ltd's share price was ₹513.30 at the close on 4 November 2026. It has been falling for 46 weeks. That is 6.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹488 and ₹720, and at that close it sat 11% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Amrutanjan Health Care Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 3 weeks in a row.

Over the last 11 years the share price moved +148% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: profit fell in the June 2026 quarter, revenue up on a year earlier for 11 quarters in a row (every quarter we can compare) and indian funds and insurers (DIIs) cut their stake for 3 quarters in a row.

1. Profit fell in the June 2026 quarter

   Profit was ₹4 crore, -47.4% on a year earlier (₹8 crore), after 7 quarters of growth.

2. Revenue up on a year earlier for 11 quarters in a row (every quarter we can compare)

   In the June 2026 quarter revenue was ₹103 crore, +9.5% on a year earlier.

3. Indian funds and insurers (DIIs) cut their stake for 3 quarters in a row

   From 13% to 6.9% of the company by the September 2026 quarter.

For April to June 2026 (the quarter ended 30 June 2026), Amrutanjan Health Care reported revenue of ₹103 crore, up 9.5% from ₹94.0 crore a year earlier, and a profit of ₹4.37 crore, down 47.4% from ₹8.31 crore.

Amrutanjan Health Care results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Amrutanjan Health Care closed at ₹513.30 on 4 November 2026, down 27.4% from ₹707.50 a year earlier (7 November 2025) and down 47.4% over five years. Its highest weekly close since March 2016 was ₹975.00 on 4 November 2021.

Amrutanjan Health Care share price: then and now

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

562 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: Amrutanjan Health Care closed at ₹513.30, up 3.3% on the week and down 0.1% on the month. 11 Sep 2026: ex-date for a dividend of ₹2.90 a share.

Earlier

• Results for April to June 2026: Revenue up 9.5% and profit down 47.4% on a year earlier.
• 6 Feb 2026: ex-date for an interim dividend of ₹1 a share, record date 7 Feb 2026.
• 18 Nov 2025: ex-date for an interim dividend of ₹1 a share.

Amrutanjan Health Care paid ₹4.90 a share in regular dividends in the 12 months to 5 November 2026 (3 payments), a yield of 0.95% at the ₹513.30 close on 4 November 2026. The last was a dividend of ₹2.90 a share, ex-date 11 September 2026.

Amrutanjan Health Care dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Amrutanjan Health Care Ltd paid out 24% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

Amrutanjan Health Care is on 2 of our India lists: 52 week high & low and Pharma stocks.

Amrutanjan Health Care Ltd earned ₹4.4 Cr of net profit in the Jun 2026 quarter, −47.4% on the same quarter a year earlier. Full-year FY26 profit was ₹58.0 Cr. Over 10 years profit has grown 10.2% a year on average. That is 4.2% of the quarter's revenue. The same quarter a year earlier earned ₹8.3 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹58.0 Cr (+13.7% on the year before).

Why profit moved: revenue changed +9.5% on a year earlier and the margin moved −2.9 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −5.3% and revenue +10.5%. Profit is growing slower than sales: rising costs are taking part of the growth.

Amrutanjan Health Care Ltd reported ₹103 Cr of revenue in the Jun 2026 quarter, +9.5% on the same quarter a year earlier. That is the 11th quarter in a row with growth on the year before. Over 10 years it has grown 11.2% a year on average. The last full year, FY26, came in at ₹503 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹511 Cr.

FY26 revenue was ₹503 Cr, +11.3% on the year before.

Recent pace: the last four quarters grew +10.5% on average, against 11.2% a year over the longer run, so this year is growing at about the same pace as its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +10.7%, against +9.4% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −1.0%, against +12.6% a year (rolling over).

Amrutanjan Health Care Ltd's operating margin was 6.1% in the Jun 2026 quarter, 2.9 percentage points lower than the same quarter a year ago. Across 13 years it has been between 12.0% and 22.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −2.9 percentage points on the year while gross margin changed −0.2 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

Over the last 3 years, 75% of Amrutanjan Health Care Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 it brought in ₹36.0 Cr of operating cash against ₹58.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹98.0 Cr of spending on assets, free cash was −₹62.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 75% of profit came in as cash: the cash cycle got 35 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: less of the profit turns into cash than it should, and the cash cycle is 35 days longer. The next section looks at where the cash is stuck.

Amrutanjan Health Care Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was −6 days in FY26, up from −41 days in FY21. It spent ₹126 Cr on assets over the last 3 years. Customers take 44 days to pay, and stock sits for 56 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹503 Cr, each day of that cycle ties up about ₹1.4 Cr, so roughly −₹8.0 Cr is tied up in the business at any time.

FY26: customers took 44 days to pay and stock sat for 56 days, about 1.8 months of sales sitting as stock, for a full cycle of −6 days, longer than FY21's −41.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 56 days. Customers pay about 44 days after that. Suppliers are paid at 106 days. Together that makes the −6-day cycle.

Spending on assets: ₹126 Cr over the last 3 years, against ₹19.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹106 Cr (FY26): assets paid for that are not earning yet.

In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit.

Amrutanjan Health Care Ltd's P/E is 23.9×, about the lowest it has ever been. Its usual P/E (the middle reading) is 40.5×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹18.67.